Entities / Company
IQVIA.
company that provides information, services and technology for the healthcare industry
- Reports this week
- 0
- Active events
- 1
- Connections
- 82
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
-
IQVIA published a white paper comparing Türkiye's obesity landscape and health metrics against European standards.Some support1 report1 development inside
-
IQVIA released data detailing usage patterns of buprenorphine.Some support1 report
-
Munich Reinsurance Co acquired a new stake in IQVIA, with disclosures filed with the SEC.Some support1 report
-
Ari Bousbib has been appointed as the chairman and CEO of IQVIA.Some support2 reports
Gone quiet
No new reports in 90+ days-
Stephens Inc. disclosed holdings to the SEC regarding its increased stake in IQVIA shares.Some support1 report
-
IQVIA Holdings is headquartered in Durham, North Carolina.Some support5 reports
-
TD Cowen upgraded IQVIA rating to buy.Some support1 report
-
A BioPharma company located in Jílové u Prahy, Czech Republic, is transitioning its funding into RFPs and bookings.Some support1 report
-
Geode Capital Management and Boston Partners increased their stakes in IQVIA during Q4.Some support1 report
-
IQVIA and Medpace reported strong earnings amid industry rebound, while China remains a key source of raw ingredients.Some support2 reports
-
Artisan Value Fund made an investment in IQVIA.Some support2 reports
-
Vulcan Value Partners highlighted IQVIA's potential benefit from Trump-era tariffs in an investor letter.Some support1 report
-
Inquiries regarding R&D ratios were made by Bank of America to IQVIA, involving representatives from Deutsche Bank and Goldman Sachs.Speculative1 report
-
A collection of unrelated facts from June 30, 2025, covering services from IQVIA and Azenta, stock returns for Kadant, and Trump's election outcome.Speculative1 report
-
IQVIA and Veeva Systems provide AI solutions in the life sciences sector.Speculative1 report
-
IQVIA announced a collaboration to develop custom AI agents.Some support1 report
-
IQVIA shares underperformed the market on July 22, 2025, with investors noting the relevance of Zacks Rank.Some support5 reports
-
Investor conviction favors AI stocks over IQVIA.Some support1 report
-
A Discounted Cash Flow (DCF) model was used on July 26, 2025, to estimate the intrinsic value of IQVIA.Some support1 report
-
IQVIA reported that Europe contributed $1.24 billion and Africa contributed $1.24 billion in revenue on July 28, 2025.Some support1 report
-
IQVIA announced on July 28, 2025, that its revenue growth forecast is lower than the industry average.Some support1 report
-
IQVIA Holdings reported having a better Return on Equity (ROE) than the industry average.Some support1 report
-
IQVIA was trading at a cheaper price relative to its peers on August 6, 2025.Some support1 report
-
Positive inflation data fueled stock gains for IQVIA and Thermo Fisher Scientific Inc. on August 13, 2025.Some support1 report
-
IQVIA and Aris Water were analyzed as cash-producing stocks on August 13, 2025.Some support1 report
-
IQVIA joined Veeva's CRO Clinical Data Partner program, allowing joint use of software and data.Some support1 report
-
IQVIA stock underperformed the broader market and the Health Care Select Sector SPDR Fund over the past year as of August 22, 2025.Some support2 reports
-
IQVIA's share price fell 24% on August 22, 2025, while the broader market gained 17%.Some support1 report
-
IQVIA announced strategic collaborations with Flagship Pioneering and Kexing Biopharm, and appointed Michael Fedock as future CFO on September 3, 2025.Well supported5 reports
-
Leading players IQVIA, Thermo Fisher, and ICON compete in the Central Lab Services market, according to a report published in Dublin.Some support1 report
-
Strategic partnerships between Microsoft, Veeva Systems, IQVIA, and SAP were announced on September 6, 2025, focusing on product integration and growth drivers like Vault CRM.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around IQVIA this week
News at the entities that move IQVIA most-
Stephens Inc. TransactionalStephens Inc. increased its investment position in the iShares Global 100 ETF on October 8, 2026.Moves IQVIA
-
Veeva Systems StructuralTD Cowen, Citigroup, and Royal Bank of Canada all raised their price targets and objectives for Veeva Systems.Moves IQVIA
-
Africa StructuralPrickly acacia is confirmed to be native to tropical Africa.Moves IQVIA
-
Securities and Exchange Commission StructuralW. R. Berkley Corporation filed its earnings release with the Securities and Exchange Commission on October 1, 2026.Moves IQVIA
-
board of directors StructuralHoffman was appointed CEO of Company by the board of directors on October 1, 2026.Moves IQVIA
-
SEC StructuralKeefe, Bruyette & Woods raised a price target while First Western Financial disclosed a CEO stock sale filing with the SEC.Moves IQVIA
Connections
The 21 strongest of 82, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Ari Bousbib Structural
Ari Bousbib holds the executive leadership roles of CEO and Chairman at IQVIA.
-
Veeva Systems Structural
IQVIA and Veeva Systems maintain a strategic partnership involving joint software use, product integration, and distribution of Veeva solutions through IQVIA's channels.
-
Sarah Cannon Research Institute Operational
IQVIA and Sarah Cannon Research Institute maintain a strategic partnership focused on accelerating and optimizing oncology clinical trials.
-
Stephens Inc. Transactional
Stephens Inc. increased its stake in IQVIA shares.
-
Africa Structural
Africa serves as a significant market and revenue contributor for IQVIA.
-
Securities and Exchange Commission Structural
IQVIA is subject to formal regulatory oversight and disclosure requirements by the Securities and Exchange Commission.
-
Geode Capital Management Transactional
Geode Capital Management increased its financial stake in IQVIA during Q4.
-
board of directors Structural
The Board of Directors governs IQVIA, authorizing major financial actions like share buybacks.
Show all 21 connections
-
SEC Structural
IQVIA is subject to regulatory oversight by the SEC, requiring the filing of insider trades.
-
Boston Partners Transactional
Boston Partners increased its financial stake in IQVIA during Q4.
-
National Heart Centre Singapore Operational
IQVIA and National Heart Centre Singapore maintain a strategic partnership.
-
Morgan Stanley Mentioned together
Morgan Stanley provides professional financial ratings and price targets for IQVIA stock, influencing market perception.
-
Medpace Mentioned together
IQVIA and Medpace are noted as peers operating within the life sciences tools segment.
-
Munich Transactional
A company based in Munich acquired a new stake in IQVIA.
-
Türkiye Shared context
IQVIA produced a white paper analyzing the obesity landscape in Türkiye.
-
BioPharma Mentioned together
The relationship is based on a single snapshot labeling the companies as competitors in a specific geographic and industry context.
-
Durham Shared context
IQVIA is headquartered in Durham, North Carolina.
-
Bangladesh Shared context
IQVIA's data is cited regarding growth trends, placing the company within the global economic context of Bangladesh.
-
TD Cowen Mentioned together
TD Cowen provided a rating upgrade for IQVIA.
-
Research Triangle Park Shared context
IQVIA is located within the Research Triangle Park area.
-
Health Canada Mentioned together
No direct coupling or interaction between Health Canada and IQVIA was observed in the provided evidence.
History
Events by the month they beganSeptember 2026
2 eventsJuly 2026
3 eventsJune 2026
27 events- A dispute between IQVIA and Veeva Systems has been resolved, opening up new avenues for collaboration between the two companies.
- IQVIA Holdings is headquartered in Durham, North Carolina.
- TD Cowen upgraded IQVIA rating to buy.
- A BioPharma company located in Jílové u Prahy, Czech Republic, is transitioning its funding into RFPs and bookings.
- Geode Capital Management and Boston Partners increased their stakes in IQVIA during Q4.
- IQVIA and Medpace reported strong earnings amid industry rebound, while China remains a key source of raw ingredients.
- Artisan Value Fund made an investment in IQVIA.
- Vulcan Value Partners highlighted IQVIA's potential benefit from Trump-era tariffs in an investor letter.
- Inquiries regarding R&D ratios were made by Bank of America to IQVIA, involving representatives from Deutsche Bank and Goldman Sachs.
- A collection of unrelated facts from June 30, 2025, covering services from IQVIA and Azenta, stock returns for Kadant, and Trump's election outcome.
- IQVIA and Veeva Systems provide AI solutions in the life sciences sector.
- IQVIA announced a collaboration to develop custom AI agents.
- IQVIA shares underperformed the market on July 22, 2025, with investors noting the relevance of Zacks Rank.
- Investor conviction favors AI stocks over IQVIA.
- A Discounted Cash Flow (DCF) model was used on July 26, 2025, to estimate the intrinsic value of IQVIA.
- IQVIA reported that Europe contributed $1.24 billion and Africa contributed $1.24 billion in revenue on July 28, 2025.
- IQVIA announced on July 28, 2025, that its revenue growth forecast is lower than the industry average.
- IQVIA Holdings reported having a better Return on Equity (ROE) than the industry average.
- IQVIA was trading at a cheaper price relative to its peers on August 6, 2025.
- Positive inflation data fueled stock gains for IQVIA and Thermo Fisher Scientific Inc. on August 13, 2025.
- IQVIA and Aris Water were analyzed as cash-producing stocks on August 13, 2025.
- IQVIA joined Veeva's CRO Clinical Data Partner program, allowing joint use of software and data.
- IQVIA stock underperformed the broader market and the Health Care Select Sector SPDR Fund over the past year as of August 22, 2025.
- IQVIA's share price fell 24% on August 22, 2025, while the broader market gained 17%.
- IQVIA announced strategic collaborations with Flagship Pioneering and Kexing Biopharm, and appointed Michael Fedock as future CFO on September 3, 2025.
- Leading players IQVIA, Thermo Fisher, and ICON compete in the Central Lab Services market, according to a report published in Dublin.
- Strategic partnerships between Microsoft, Veeva Systems, IQVIA, and SAP were announced on September 6, 2025, focusing on product integration and growth drivers like Vault CRM.